Last update 01 Nov 2024
Beijing Taiyang Pharmaceutical Co. Ltd.

Beijing Taiyang Pharmaceutical Co. Ltd.

Private Company|
1992|
Beijing Shi, China
|
taiyangpharm.cn

Overview

Tags

Otorhinolaryngologic Diseases
Endocrinology and Metabolic Disease
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Hemic and Lymphatic Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
50S subunit(50S ribosomal subunit)1
PPARγ(Peroxisome proliferator-activated receptor γ)1

Related

2
Drugs associated with Beijing Taiyang Pharmaceutical Co. Ltd.
Pioglitazone Hydrochloride
Target
PPARγ
Mechanism
PPARγ agonists
Active Org.
Takeda Pharmaceuticals U.S.A., Inc. [+6]
Originator Org.
Takeda Pharmaceutical Co., Ltd.Takeda Pharmaceutical Co., Ltd.
Active Indication
Diabetes Mellitus, Type 2
Inactive Indication
Alzheimer Disease [+20]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date15 Jul 1999
Azithromycin
Target
50S subunit
Mechanism
50S subunit inhibitors
Active Org.
Shinpoong Pharmaceutical Co., Ltd. [+7]
Originator Org.
Pfizer Inc.Pfizer Inc.
Active Indication
Genital infection [+33]
Inactive Indication
Acne Vulgaris [+20]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
AU
First Approval Date08 Apr 1994
1
Clinical Trials associated with Beijing Taiyang Pharmaceutical Co. Ltd.
CTR20180792 / Completed
盐酸氨溴索片（30 mg）随机、开放、两周期、两交叉健康人体空腹和餐后状态下生物等效性试验
[Translation] A randomized, open-label, two-period, two-crossover bioequivalence study of ambroxol hydrochloride tablets (30 mg) in healthy volunteers under fasting and fed conditions
100 Clinical Results associated with Beijing Taiyang Pharmaceutical Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Beijing Taiyang Pharmaceutical Co. Ltd.
Login to view more data
100 Deals associated with Beijing Taiyang Pharmaceutical Co. Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Taiyang Pharmaceutical Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Azithromycin
 ( 50S subunit )		Bacterial Infections
More
Approved
Pioglitazone Hydrochloride
 ( PPARγ )		Diabetes Mellitus, Type 2
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free